148 related articles for article (PubMed ID: 16183558)
1. Integrating preferences into health status assessment for amyotrophic lateral sclerosis: the ALS Utility Index.
Beusterien K; Leigh N; Jackson C; Miller R; Mayo K; Revicki D
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):169-76. PubMed ID: 16183558
[TBL] [Abstract][Full Text] [Related]
2. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].
Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S
No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837
[TBL] [Abstract][Full Text] [Related]
3. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
[TBL] [Abstract][Full Text] [Related]
4. [Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].
Atsuta N; Watanabe H; Ito M; Nakamura R; Senda J; Kato S; Sobue G
Brain Nerve; 2011 May; 63(5):491-6. PubMed ID: 21515929
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and reliability of a mailed questionnaire to obtain visual analogue scale valuations for health states defined by the Health Utilities Index Mark 3.
Raat H; Bonsel GJ; Hoogeveen WC; Essink-Bot ML;
Med Care; 2004 Jan; 42(1):13-8. PubMed ID: 14713735
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a self-administered version of the ALSFRS-R.
Montes J; Levy G; Albert S; Kaufmann P; Buchsbaum R; Gordon PH; Mitsumoto H
Neurology; 2006 Oct; 67(7):1294-6. PubMed ID: 17030772
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis.
Peric' S; Rakocevic-Stojanovic V; Stevic Z; Basta I; Pavlovic S; Vujanac V; Marjanovic L; Lavrnic D
Acta Neurol Belg; 2010 Mar; 110(1):71-7. PubMed ID: 20514929
[TBL] [Abstract][Full Text] [Related]
8. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
9. Measuring health state preferences for hemophilia: development of a disease-specific utility instrument.
Wasserman J; Aday LA; Begley CE; Ahn C; Lairson DR
Haemophilia; 2005 Jan; 11(1):49-57. PubMed ID: 15660989
[TBL] [Abstract][Full Text] [Related]
10. Measuring mental health in amyotrophic lateral sclerosis (ALS): a comparison of the SF-36 Mental Health Index with the Psychological General Well-Being Index.
Peto V; Jenkinson C; Fitzpatrick R; Swash M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Dec; 2(4):197-201. PubMed ID: 11958731
[TBL] [Abstract][Full Text] [Related]
11. Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain.
López-Bastida J; Perestelo-Pérez L; Montón-Alvarez F; Serrano-Aguilar P; Alfonso-Sanchez JL
Amyotroph Lateral Scler; 2009 Aug; 10(4):237-43. PubMed ID: 18821088
[TBL] [Abstract][Full Text] [Related]
12. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in amyotrophic lateral sclerosis.
Bromberg MB
Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):591-605, x-xi. PubMed ID: 18625418
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of variables that have an impact on noncancer end-of-life diagnoses.
Dobratz M
Clin Nurs Res; 2004 Nov; 13(4):309-25. PubMed ID: 15448282
[TBL] [Abstract][Full Text] [Related]
15. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
16. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.
Maessen M; Post MW; Maillé R; Lindeman E; Mooij R; Veldink JH; van den Berg LH
Amyotroph Lateral Scler; 2007 Apr; 8(2):96-100. PubMed ID: 17453637
[TBL] [Abstract][Full Text] [Related]
17. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey.
Jenkinson C; Fitzpatrick R; Swash M; Jones G
Clin Rehabil; 2007 Mar; 21(3):266-72. PubMed ID: 17329284
[TBL] [Abstract][Full Text] [Related]
19. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
20. The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS.
Simmons Z; Felgoise SH; Bremer BA; Walsh SM; Hufford DJ; Bromberg MB; David W; Forshew DA; Heiman-Patterson TD; Lai EC; McCluskey L
Neurology; 2006 Nov; 67(9):1659-64. PubMed ID: 17101900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
